The US FDA study is intended to evaluate the system for treating life-threatening ventricular tachyarrhythmias.

AtaCor Medical, Inc., a privately-held medical device company focused on transforming cardiac rhythm management systems, ...

Researchers report favorable safety and efficacy for a combination device after implantation and at 6 months follow-up among ...

Soccer player Christian Eriksen is to have an implantable cardioverter-defibrillator (ICD) device fitted, the Danish football federation has said. Eriksen suffered a cardiac arrest and collapsed on ...

Multiple societies covering cardiovascular medicine, electrophysiology, heart failure, and imaging have released updated appropriate use criteria (AUC) for various cardiac implantable electronic ...

AtaCor Medical announced today that it entered a financing worth up to $75 million to support its U.S. FDA pivotal study.

Physicians who receive money from manufacturers of implantable cardioverter-defibrillators (ICDs) and cardiac resynchronization therapy-defibrillators (CRT-Ds)—for activities as diverse as consulting, ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window The heart is a ...

A study of heart failure patients who meet national guidelines for devices that stabilize and strengthen the heart's electrical system found that only half of eligible patients received the devices.

FLINT, Mich. (WNEM) - A mid-Michigan hospital has become one of the first in the country to successfully implant a next-generation cardioverter-defibrillator for patients with dangerously fast or ...